SUN PHARMACEUTICAL INDUSTRIES
Back to Income Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹16,491 Cr | ₹15,086 Cr | ₹12,749 Cr | ₹11,588 Cr | ₹9,882 Cr |
What is the latest Operating Profit of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹16,491 Cr |
| Mar2025 | ₹15,086 Cr |
| Mar2024 | ₹12,749 Cr |
| Mar2023 | ₹11,588 Cr |
| Mar2022 | ₹9,882 Cr |
How is Operating Profit of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹16,491 Cr | 9.31 | |
| Mar2025 | ₹15,086 Cr | 18.33 | |
| Mar2024 | ₹12,749 Cr | 10.02 | |
| Mar2023 | ₹11,588 Cr | 17.26 | |
| Mar2022 | ₹9,882 Cr | - | |
Compare Operating Profit of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,269.8 Cr | -0.3% | -3.1% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,531.0 Cr | -1.3% | 2.2% | 57.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,957.0 Cr | -1.3% | -2.4% | 33.3% | Stock Analytics | |
| CIPLA | ₹111,729.0 Cr | 0.2% | -2.5% | -9.1% | Stock Analytics | |
| MANKIND PHARMA | ₹105,120.0 Cr | 3.4% | 6.6% | -4.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,335.0 Cr | 3.3% | 6.1% | -6.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -0.3% |
-3.1% |
12.8% |
| SENSEX | -2.7% |
-5.7% |
-11.7% |
You may also like the below Video Courses